IN2014CN04693A - - Google Patents

Download PDF

Info

Publication number
IN2014CN04693A
IN2014CN04693A IN4693CHN2014A IN2014CN04693A IN 2014CN04693 A IN2014CN04693 A IN 2014CN04693A IN 4693CHN2014 A IN4693CHN2014 A IN 4693CHN2014A IN 2014CN04693 A IN2014CN04693 A IN 2014CN04693A
Authority
IN
India
Prior art keywords
scymnol
ester
patient
seborrhoea
treatment
Prior art date
Application number
Other languages
English (en)
Inventor
Theodore Macrides
Andrew Broadbent
Original Assignee
Mcfarlane Marketing Aust Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2011905331A external-priority patent/AU2011905331A0/en
Application filed by Mcfarlane Marketing Aust Pty Ltd filed Critical Mcfarlane Marketing Aust Pty Ltd
Publication of IN2014CN04693A publication Critical patent/IN2014CN04693A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/008Preparations for oily skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
IN4693CHN2014 2011-12-20 2012-12-14 IN2014CN04693A (enrdf_load_stackoverflow)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2011905331A AU2011905331A0 (en) 2011-12-20 Treatment of seborrhoea
AU2012900670A AU2012900670A0 (en) 2012-02-22 Treatment of seborrhoea
PCT/AU2012/001543 WO2013090986A1 (en) 2011-12-20 2012-12-14 Treatment of seborrhoea

Publications (1)

Publication Number Publication Date
IN2014CN04693A true IN2014CN04693A (enrdf_load_stackoverflow) 2015-09-18

Family

ID=48667492

Family Applications (1)

Application Number Title Priority Date Filing Date
IN4693CHN2014 IN2014CN04693A (enrdf_load_stackoverflow) 2011-12-20 2012-12-14

Country Status (20)

Country Link
US (1) US20140364405A1 (enrdf_load_stackoverflow)
EP (1) EP2793897B1 (enrdf_load_stackoverflow)
JP (1) JP2015500841A (enrdf_load_stackoverflow)
KR (1) KR20140120890A (enrdf_load_stackoverflow)
CN (1) CN104144689A (enrdf_load_stackoverflow)
AU (1) AU2012321108B2 (enrdf_load_stackoverflow)
BR (1) BR112014014968A2 (enrdf_load_stackoverflow)
CA (1) CA2859826A1 (enrdf_load_stackoverflow)
DK (1) DK2793897T3 (enrdf_load_stackoverflow)
ES (1) ES2632591T3 (enrdf_load_stackoverflow)
HU (1) HUE033800T2 (enrdf_load_stackoverflow)
IN (1) IN2014CN04693A (enrdf_load_stackoverflow)
MX (1) MX2014007659A (enrdf_load_stackoverflow)
MY (1) MY165030A (enrdf_load_stackoverflow)
PL (1) PL2793897T3 (enrdf_load_stackoverflow)
PT (1) PT2793897T (enrdf_load_stackoverflow)
RU (1) RU2624238C2 (enrdf_load_stackoverflow)
SG (1) SG11201403078RA (enrdf_load_stackoverflow)
WO (1) WO2013090986A1 (enrdf_load_stackoverflow)
ZA (1) ZA201404348B (enrdf_load_stackoverflow)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1296322C (en) * 1986-08-21 1992-02-25 Takuo Kosuge Active principle isolated from shark tissue
ZA947912B (en) * 1993-10-12 1995-05-24 Broadbent J W Nominees Pty Ltd Treatment of medical disorders associated with free radical formation
JP2007063139A (ja) * 2005-08-29 2007-03-15 Daicho Kikaku:Kk 皮膚用剤
JP2007244325A (ja) * 2006-03-17 2007-09-27 Daicho Kikaku:Kk 新しい健康食品

Also Published As

Publication number Publication date
EP2793897A1 (en) 2014-10-29
HUE033800T2 (en) 2018-01-29
DK2793897T3 (en) 2017-07-31
CA2859826A1 (en) 2013-06-27
BR112014014968A2 (pt) 2017-06-13
KR20140120890A (ko) 2014-10-14
JP2015500841A (ja) 2015-01-08
AU2012321108B2 (en) 2015-07-09
SG11201403078RA (en) 2014-07-30
WO2013090986A1 (en) 2013-06-27
MY165030A (en) 2018-02-28
PT2793897T (pt) 2017-07-17
EP2793897A4 (en) 2015-04-08
CN104144689A (zh) 2014-11-12
MX2014007659A (es) 2014-11-14
AU2012321108A1 (en) 2013-07-04
ZA201404348B (en) 2016-10-26
ES2632591T3 (es) 2017-09-14
US20140364405A1 (en) 2014-12-11
PL2793897T3 (pl) 2017-10-31
RU2624238C2 (ru) 2017-07-03
RU2014126635A (ru) 2016-02-10
NZ625852A (en) 2015-07-31
HK1199818A1 (en) 2015-07-24
EP2793897B1 (en) 2017-04-12

Similar Documents

Publication Publication Date Title
AU2012214029A8 (en) Rorgammat inhibitors
UA115139C2 (uk) Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту
MX350745B (es) El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia.
MX356728B (es) Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2.
IN2014CN04634A (enrdf_load_stackoverflow)
WO2012071369A3 (en) A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease
PH12012501358A1 (en) Treatment method
UA111475C2 (uk) Способи лікування із застосуванням ліпідних сполук
PH12014500990A1 (en) Methods for treating gout flares
PH12014500381A1 (en) Therapeutic methods
MX2014014814A (es) Composicion farmaceutica para el tratamiento de inflamacion y dolor.
MX2013010415A (es) Tratamiento de la atrofia vaginal con nueva indicacion para la mirra.
MY195767A (en) Treatment of Androgen Deprivation Therapy Associated Symptoms
IN2014CN04693A (enrdf_load_stackoverflow)
PH12014500684A1 (en) Treatment of rhinitis
WO2012112862A3 (en) Treating mycobacterial infection with cu+/++ boosting therapeutics
WO2013015634A3 (en) Pharmaceutical composition for treating atopic dermatitis
UA65038U (ru) Способ лечения больных послеродовыми психозами
UA52204U (ru) Способ катетерной интраоперационной склеротерапии при лечении варикозной болезни
UA60148U (ru) Способ лечения больных неалкогольным стеатогепатитом
UA59700U (ru) Способ лечения метаболического синдрома
UA55818U (ru) Способ лечения хронических заболеваний роговицы
UA58758U (ru) Способ коррекции иммунного статуса больных с неалкогольным стеатогепатитом
UA53280U (ru) Способ лечения больных стабильной стенокардией напряжения
UA69222U (ru) Способ рефлексотерапии больных с отдаленными последствиями черепно-мозговой травмы